317 related articles for article (PubMed ID: 35650448)
1. Predictive Design and Analysis of Drug Transport by Multiscale Computational Models Under Uncertainty.
Akalın AA; Dedekargınoğlu B; Choi SR; Han B; Ozcelikkale A
Pharm Res; 2023 Feb; 40(2):501-523. PubMed ID: 35650448
[TBL] [Abstract][Full Text] [Related]
2. The role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systems.
Haddish-Berhane N; Rickus JL; Haghighi K
Int J Nanomedicine; 2007; 2(3):315-31. PubMed ID: 18019831
[TBL] [Abstract][Full Text] [Related]
3. Multiscale Modeling in the Clinic: Drug Design and Development.
Clancy CE; An G; Cannon WR; Liu Y; May EE; Ortoleva P; Popel AS; Sluka JP; Su J; Vicini P; Zhou X; Eckmann DM
Ann Biomed Eng; 2016 Sep; 44(9):2591-610. PubMed ID: 26885640
[TBL] [Abstract][Full Text] [Related]
4. Multiscale Computational Modeling of Vascular Adaptation: A Systems Biology Approach Using Agent-Based Models.
Corti A; Colombo M; Migliavacca F; Rodriguez Matas JF; Casarin S; Chiastra C
Front Bioeng Biotechnol; 2021; 9():744560. PubMed ID: 34796166
[TBL] [Abstract][Full Text] [Related]
5. Multiscale modeling of protein membrane interactions for nanoparticle targeting in drug delivery.
Eckmann DM; Bradley RP; Kandy SK; Patil K; Janmey PA; Radhakrishnan R
Curr Opin Struct Biol; 2020 Oct; 64():104-110. PubMed ID: 32731155
[TBL] [Abstract][Full Text] [Related]
6. Mathematical and computational modeling of nano-engineered drug delivery systems.
Shamsi M; Mohammadi A; Manshadi MKD; Sanati-Nezhad A
J Control Release; 2019 Aug; 307():150-165. PubMed ID: 31229474
[TBL] [Abstract][Full Text] [Related]
7. Rational nanoparticle design: Optimization using insights from experiments and mathematical models.
Richfield O; Piotrowski-Daspit AS; Shin K; Saltzman WM
J Control Release; 2023 Aug; 360():772-783. PubMed ID: 37442201
[TBL] [Abstract][Full Text] [Related]
8. Ignoring the modeling approaches: Towards the shadowy paths in nanomedicine.
Hassanzadeh P; Atyabi F; Dinarvand R
J Control Release; 2018 Jun; 280():58-75. PubMed ID: 29723612
[TBL] [Abstract][Full Text] [Related]
9. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies.
Moradi Kashkooli F; Soltani M; Souri M
J Control Release; 2020 Nov; 327():316-349. PubMed ID: 32800878
[TBL] [Abstract][Full Text] [Related]
10. Applying artificial intelligence and computational modeling to nanomedicine.
Hamilton S; Kingston BR
Curr Opin Biotechnol; 2024 Feb; 85():103043. PubMed ID: 38091874
[TBL] [Abstract][Full Text] [Related]
11. In Silico Models for Nanomedicine: Recent Developments.
Mascheroni P; Schrefler BA
Curr Med Chem; 2018; 25(34):4192-4207. PubMed ID: 28911299
[TBL] [Abstract][Full Text] [Related]
12. Vivarium: an interface and engine for integrative multiscale modeling in computational biology.
Agmon E; Spangler RK; Skalnik CJ; Poole W; Peirce SM; Morrison JH; Covert MW
Bioinformatics; 2022 Mar; 38(7):1972-1979. PubMed ID: 35134830
[TBL] [Abstract][Full Text] [Related]
13. Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases.
Sims LB; Miller HA; Halwes ME; Steinbach-Rankins JM; Frieboes HB
Eur J Pharm Biopharm; 2019 May; 138():37-47. PubMed ID: 30195726
[TBL] [Abstract][Full Text] [Related]
14. Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis Tools.
Kutumova EO; Akberdin IR; Kiselev IN; Sharipov RN; Egorova VS; Syrocheva AO; Parodi A; Zamyatnin AA; Kolpakov FA
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293410
[TBL] [Abstract][Full Text] [Related]
15. Multiscale modeling of mucosal immune responses.
Mei Y; Abedi V; Carbo A; Zhang X; Lu P; Philipson C; Hontecillas R; Hoops S; Liles N; Bassaganya-Riera J
BMC Bioinformatics; 2015; 16 Suppl 12(Suppl 12):S2. PubMed ID: 26329787
[TBL] [Abstract][Full Text] [Related]
16. Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation.
Cevaal PM; Roche M; Lewin SR; Caruso F; Faria M
J Vis Exp; 2022 Sep; (187):. PubMed ID: 36282696
[TBL] [Abstract][Full Text] [Related]
17. A Vision for the Future of Multiscale Modeling.
Capone M; Romanelli M; Castaldo D; Parolin G; Bello A; Gil G; Vanzan M
ACS Phys Chem Au; 2024 May; 4(3):202-225. PubMed ID: 38800726
[TBL] [Abstract][Full Text] [Related]
18. How can machine learning and multiscale modeling benefit ocular drug development?
Wang N; Zhang Y; Wang W; Ye Z; Chen H; Hu G; Ouyang D
Adv Drug Deliv Rev; 2023 May; 196():114772. PubMed ID: 36906232
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in multiscale CFD modelling of cooling processes and systems for the agrifood industry.
Ajani CK; Zhu Z; Sun DW
Crit Rev Food Sci Nutr; 2021; 61(15):2455-2470. PubMed ID: 32880478
[TBL] [Abstract][Full Text] [Related]
20. Development of a Physiologically-Based Mathematical Model for Quantifying Nanoparticle Distribution in Tumors.
Dogra P; Chuang YL; Butner JD; Cristini V; Wang Z
Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():2852-2855. PubMed ID: 31946487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
